Menu Search
Equities

Life Healthcare Group Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
L53:FRA

Life Healthcare Group Holdings Ltd

Actions
  • Price (EUR)0.65
  • Today's Change-0.005 / -0.76%
  • Shares traded--
  • 1 Year change+4.00%
  • Beta0.3794
Data delayed at least 15 minutes, as of Jul 18 2025 07:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Life Healthcare Group Holdings Limited is a South Africa-based diversified healthcare provider. The Company offers acute care and complementary services, including emergency care, mental health, acute rehabilitation, renal dialysis, oncology, diagnostics, and nuclear medicine. Its segments include Southern Africa and International. The Southern Africa segment includes acute hospitals and complementary services, encompassing mental health, acute rehabilitation, renal dialysis, oncology, and diagnostics, which cover imaging and nuclear medicine. Additionally, it provides healthcare services, comprising Life Nkanyisa and Life Health Solutions. The International segment focuses on radiopharmaceutical products developed by Life Molecular Imaging. It operates approximately 48 hospital facilities in Southern Africa, nine mental healthcare facilities, seven acute rehabilitation centers, 71 renal dialysis facilities, five oncology centers, and 13 diagnostic and nuclear imaging facilities.

  • Revenue in ZAR (TTM)25.91bn
  • Net income in ZAR-762.00m
  • Incorporated2003
  • Employees16.25k
  • Location
    Life Healthcare Group Holdings LtdBuilding 2, Oxford Parks,203 Oxford Road, Cnr Eastwood and OxfoDUNKELD 2196South AfricaZAF
  • Phone+27 112199000
  • Fax+27 112199001
  • Websitehttps://www.lifehealthcare.co.za/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.